Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.49), $0.20 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.